ADDMEDICA
DDMEDICA is a medical product company based in France dedicated to adding innovative and personalized responses for patients who suffer from rare diseases or serious medical conditions. Currently, there are many unmet medical needs for products to be used together with, or instead of, drugs in niche markets or rare diseases. Addressing this unique market requires a specific know-how and a dedicated European organisation. ADDMEDICA is capable of targeting such medical products throughout the world and to procure them for health professionals and/or patients.
ADDMEDICA
Social Links:
Industry:
Biotechnology Health Care Pharmaceutical
Founded:
2005-01-01
Address:
Paris, Ile-de-France, France
Country:
France
Website Url:
http://www.addmedica.com
Total Employee:
11+
Status:
Active
Contact:
+33 1 72 69 01 86
Technology used in webpage:
IPv6 Person Schema Gravatar Profiles French Server Location
Similar Organizations
Amyndas Pharmaceuticals S.A.
Amyndas is a pharmaceutical company
Aposcience AG
Aposcience AG is a biopharmaceutical company.
MEDRAY IMAGING
MEDRAY IMAGING is a medical diagnostic imaging center.
MERLIN
MERLIN is a microbiological diagnostics company.
Current Employees Featured
Founder
Investors List
Mérieux Equity Partners
Mérieux Equity Partners investment in Private Equity Round - addmedica
Official Site Inspections
http://www.addmedica.com Semrush global rank: 9.91 M Semrush visits lastest month: 292
- Host name: server.astuce-bellevie.com
- IP address: 188.130.45.253
- Location: France
- Latitude: 48.8582
- Longitude: 2.3387
- Timezone: Europe/Paris
More informations about "addmedica"
About addmedica
Founded in 2005, Addmedica is a European-based privately owned Specialty Pharma Company focused on developing and marketing medical products for Rare Diseases and Niche Markets. …See details»
addmedica Add more life - Welcome to addmedica
About addmedica and therapeutic areas. Passer au contenu. About addmedica; Therapeutic areas; Countries; Contact; addmedica Eric Godallier 2020-01-23T11:38:32+02:00. Add more …See details»
addmedica - Crunchbase Company Profile & Funding
Who invested in addmedica? addmedica is funded by Mérieux Equity Partners. When was the last funding round for addmedica? addmedica closed its last funding round on Dec 11, 2019 from a …See details»
addmedica - LinkedIn
Addmedica is a fast growing company focused on developing and marketing medical products for: • rare diseases • unmet medical needs in developed and emerging countries • serious …See details»
AddMedica - Overview, News & Similar companies | ZoomInfo.com
Who is AddMedica. Founded in 2005, Addmedica is a Paris-based Specialty Pharma Company focused on developing and marketing medical products for Rare Diseases and Nic he …See details»
Addmedica Company Profile 2024: Valuation, Investors …
When was Addmedica founded? Addmedica was founded in 2005. Where is Addmedica headquartered? Addmedica is headquartered in Paris, France. What is the size of Addmedica? Addmedica has 31 total employees. What industry …See details»
Addmedica SAS - Drug pipelines, Patents, Clinical trials - Synapse
Explore Addmedica SAS with its drug pipeline, therapeutic area, technology platform, 7 clinical trials, Drug:Hydroxycarbamide. ... The statistics for drugs in the Pipeline is the current …See details»
Addmedica | VentureRadar
Created in 2005, ADDMEDICA is a fast growing European company focused on developing and marketing medical products for: Rare diseases, Serious conditions, Unmet medical needs. Bio …See details»
Organization | Addmedica
Organization Overview. First Clinical Trial. 2015 NCT02522104. First Marketed Drug. 2017 hydroxyurea . First NDA Approval. None Last Known Activity ... ADDMEDICA SAS | …See details»
addmedica - Contacts, Employees, Board Members, Advisors
Organization. addmedica . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. Highlights. Employee Profiles 4. About. addmedica has 4 …See details»
Addmedica Company Profile - Office Locations, Competitors
Addmedica is a company engaged in the development and marketing of medical products. Its areas of interest comprise wound healing, tissue growth and cell regeneration, organ …See details»
Addmedica - Company Profile - Tracxn
Nov 4, 2024 Addmedica - Developer of drug therapeutics for rare disease. Raised funding over 1 round from 1 investor. Founded by Bernard Dauvergne in the year 2005. Addmedica has 39 …See details»
Addmedica - Products, Competitors, Financials, Employees, …
Addmedica manufactures personalized medical products for treating patients with rare and serious medical conditions. Use the CB Insights Platform to explore Addmedica's full profile. …See details»
Countries - AddMedica
About addmedica; Therapeutic areas; Countries; Contact; Countries Eric Godallier 2021-11-08T12:00:38+02:00. Choose your countrySee details»
Addmedica
ADDMEDICA is actively engaged against sickle cell disease. Sickle Cell disease (SCD) is a genetic disease affecting red blood cells. Sickle-cell disease (SCD), or sickle-cell anaemia …See details»
Addmedica, Inc. Company Profile | Miami, FL - Dun & Bradstreet
Find company research, competitor information, contact details & financial data for Addmedica, Inc. of Miami, FL. Get the latest business insights from Dun & Bradstreet.See details»
What is Addmedica? Company Culture, Mission, Values
See what employees say it's like to work at Addmedica. Salaries, reviews, and more - all posted by employees working at Addmedica.See details»
Addmedica - VentureRadar
Created in 2005, ADDMEDICA is a fast growing European company focused on developing and marketing medical products for: Rare diseases, Serious conditions, Unmet medical needs. Bio …See details»
United Kingdom - AddMedica
ADDMEDICA If you have a medical inquiry, or need to report a side effect of Siklos in the United Kingdom, please contact us at [email protected] Tel: +44-(0)203-695 9305. …See details»
Supreme Group Acquires Amendola, an Award-Winning …
2 days ago Fifth acquisition joins growing platform of world-class health-focused businesses WEST CHESTER, PA AND SCOTTSDALE, AZ, Dec. 4, 2024—Supreme Group today …See details»